海特生物前三季度净利亏损1.58亿元

Core Viewpoint - Hite Bio's Q3 2025 financial report indicates significant declines in both revenue and net profit, reflecting ongoing challenges in the company's performance [1] Financial Performance - For the first three quarters of 2025, the company achieved revenue of 422 million yuan, a year-on-year decrease of 6.45% [1] - The net profit attributable to shareholders for the same period was -158 million yuan, representing a year-on-year decline of 297.78% [1] - In Q3 2025, the company's revenue was 147 million yuan, down 11.7% year-on-year [1] - The net profit for Q3 was -119 million yuan, showing a drastic year-on-year decrease of 600.39% [1]